相关产品推荐更多 >

CD68 Antibody;阿拉丁ExactAb™, 无载体, 已验证, 1.0 mg/mL;阿拉丁
¥499.90
Recombinant IL-10 Antibody;阿拉丁ExactAb™, 已验证, 重组, 见COA;阿拉丁
¥499.90
Setrusumab (anti-Sclerostin),1847394-95-9,ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥669.90
PF-03732010 (anti-CDH3),ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥669.90
PY159 (anti-TREM1),Carrier Free, 重组, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot,阿拉丁
¥669.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-80℃储存;避免反复冻融
- 库存:
现货
- 供应商:
上海阿拉丁生化科技股份有限公司
- 浓度:
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
- 规格:
Ab182836-5mg/Ab182836-1mg/Ab182836-10mg/Ab182836-100μg
| 规格: | Ab182836-5mg | 产品价格: | ¥15499.9 |
|---|---|---|---|
| 规格: | Ab182836-1mg | 产品价格: | ¥6199.9 |
| 规格: | Ab182836-10mg | 产品价格: | ¥24799.9 |
| 规格: | Ab182836-100μg | 产品价格: | ¥1239.9 |
设定黄金标准,在阿拉丁,我们不仅相信保持质量,而且相信质量。 我们的目标是定义它。 我们的质量管理理念为业界研究试剂建立了高质量的标准。 当您听到阿拉丁这个名字时,就会知道它是各个方面坚定不移品质的灯塔。
中文名:Odronextamab (anti-CD20&CD3)
英文名:Odronextamab (anti-CD20&CD3)
纯度:ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
cas号:1801338-64-6
存储温度:-80℃储存;避免反复冻融
运输条件:超低温冰袋运输
产品介绍:
Odronextamab (anti-CD20&CD3) 是一种稳定的人源化 IgG4 的 CD20 × CD3 双特异性抗体,可结合 T 细胞上的 CD3 和 B 细胞上的 CD20。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RNase Protection Assay(RPA)操作步骤
, and the construct can then be used as a template for synthesis or radiolabeled anti-sense RNA probes. Pharmingen's strategy for the development of multi-probe RPA systems is to generate a series of apoptosis-related gene templates, each of distinct length
Introduction Natural genetic transformation is a process by which bacteria are able to take up and integrate exogenous free DNA from their environment (1 , 2 ). This process enables the recipient organisms to acquire novel genes
Peter Järver and Ülo Langel. The use of cell-penetrating peptides as a tool for gene regulation Drug Discovery Today (DDT). 2004, 9(9): 395-402. The use of cell-penetrating peptides as a tool for gene regulation A novel carrier
技术资料暂无技术资料 索取技术资料





